Last reviewed · How we verify
Crenezumb dose level 3
At a glance
| Generic name | Crenezumb dose level 3 |
|---|---|
| Sponsor | Genentech, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Crenezumb dose level 3 CI brief — competitive landscape report
- Crenezumb dose level 3 updates RSS · CI watch RSS
- Genentech, Inc. portfolio CI